Functional regeneration at the blood-biomaterial interface

Adv Drug Deliv Rev. 2023 Sep 9;201:115085. doi: 10.1016/j.addr.2023.115085. Online ahead of print.ABSTRACTThe use of cardiovascular implants is commonplace in clinical practice. However, reproducing the key bioactive and adaptive properties of native cardiovascular tissues with an artificial replacement is highly challenging. Exciting new treatment strategies are under development to regenerate (parts of) cardiovascular tissues directly in situ using immunomodulatory biomaterials. Direct exposure to the bloodstream and hemodynamic loads is a particular challenge, given the risk of thrombosis and adverse remodeling that it brings. However, the blood is also a source of (immune) cells and proteins that dominantly contribute to functional tissue regeneration. This review explores the potential of the blood as a source for the complete or partial in situ regeneration of cardiovascular tissues, with a particular focus on the endothelium, being the natural blood-tissue barrier. We pinpoint the current scientific challenges to enable rational engineering and testing of blood-contacting implants to leverage the regenerative potential of the blood.PMID:37690484 | DOI:10.1016/j.addr.2023.115085
Source: Advanced Drug Delivery Reviews - Category: Drugs & Pharmacology Authors: Source Type: research